Product Information
CLINDAMYCIN PHOSPHATE 1% GEL is a generic product labeled by Solaris Pharma Corporation, priced at $3.4015 per ML under NDC 73473030275. Its NADAC has been published 220 times since Jun 22, 2022.
FDA first approved this application on Aug 13, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/10mL
Manufacturer
Solaris Pharma CorporationNDC
73473030275
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212842FDA Approved
8/13/2021
TE Code
AB2
On Market Since
9/15/2024
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOSPHATE 1% GEL has been published 220 times since Jun 22, 2022, and over the history we have for it it has declined 63.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4015 per ML |
|---|---|
| All-time high | $9.4149 (Aug 16, 2023) |
| All-time low | $3.4015 (Sep 23, 2026) |
| 52-week high | $8.0026 |
| 52-week low | $3.4015 |
| Median price | $5.6550 |
| Average price | $6.4998 |
| Largest weekly change | -43.9% (Sep 20, 2023) |
| Weeks tracked | 220 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solaris Pharma Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% GEL, manufactured by Solaris Pharma Corporation, is $3.4015 per ML (NDC 73473030275), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOSPHATE 1% GEL changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% GEL has declined 63.9%. It has been tracked across 220 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% GEL?
Since Jun 22, 2022, the NADAC for CLINDAMYCIN PHOSPHATE 1% GEL has ranged from a low of $3.4015 (Sep 23, 2026) to a high of $9.4149 (Aug 16, 2023), with a median of $5.6550 per ML.
Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% GEL?
No other NADAC-published product currently shares the active ingredient and strength of CLINDAMYCIN PHOSPHATE 1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLINDAMYCIN PHOSPHATE 1% GEL?
CLINDAMYCIN PHOSPHATE 1% GEL (NDC 73473030275) is labeled by Solaris Pharma Corporation, and CMS classifies it as a generic product.